Explore more publications!
Health Observer Falkland Islands
Got News to Share?

Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on February 20, 2026

Emergency Medical Services Software Market: Analysis of Future Demand and Leading Key Players through 2030
Feb. 20, 2026

Emergency Medical Services Software Market: Analysis of Future Demand and Leading Key Players through 2030

Indeterminate EIN Presswire
Embolization Product Market Drivers from 2026 to 2030: Analysis of Regional Trends and Market Size
Feb. 20, 2026

Embolization Product Market Drivers from 2026 to 2030: Analysis of Regional Trends and Market Size

Indeterminate EIN Presswire
Drug Development Services Market by Application, Industry, Region and Segment with Forecast to 2030
Feb. 20, 2026

Drug Development Services Market by Application, Industry, Region and Segment with Forecast to 2030

Indeterminate EIN Presswire
Atopic Disease Therapeutics Market Set to Witness Significant Growth by 2026-2033 | Astellas Pharma Inc, Bayer AG
Feb. 20, 2026

Atopic Disease Therapeutics Market Set to Witness Significant Growth by 2026-2033 | Astellas Pharma Inc, Bayer AG

Indeterminate EIN Presswire
Nebivolol Tablets Market Set to Witness Massive Growth by 2033 | AstraZeneca, Novartis, Ranbaxy Laboratories
Feb. 20, 2026

Nebivolol Tablets Market Set to Witness Massive Growth by 2033 | AstraZeneca, Novartis, Ranbaxy Laboratories

Indeterminate EIN Presswire
Cochineal Extract Market Witnessing High Growth | Demand, Size & Regional Analysis 2026-2033 | Diana Food, BASF SE
Feb. 20, 2026

Cochineal Extract Market Witnessing High Growth | Demand, Size & Regional Analysis 2026-2033 | Diana Food, BASF SE

Indeterminate EIN Presswire
Caffeine Gummies Market Growth Overview, Facts & Figures, Segmentation, Future Trends and Historical Analysis By 2033
Feb. 20, 2026

Caffeine Gummies Market Growth Overview, Facts & Figures, Segmentation, Future Trends and Historical Analysis By 2033

Indeterminate EIN Presswire
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment
Feb. 20, 2026

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

Indeterminate GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Feb. 20, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
Feb. 20, 2026

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

Indeterminate GlobeNewswire
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Feb. 20, 2026

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb. 20, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Feb. 20, 2026

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb. 20, 2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb. 20, 2026

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
Feb. 20, 2026

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

Indeterminate GlobeNewswire
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
Feb. 20, 2026

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

Indeterminate GlobeNewswire
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Feb. 20, 2026

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults

Indeterminate GlobeNewswire
Sadhguru Presents Innovative AI Hologram Tech at Massive Event
Feb. 20, 2026

Sadhguru Presents Innovative AI Hologram Tech at Massive Event

Indeterminate GlobeNewswire
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting
Feb. 20, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions